Understanding the genetic alterations in hereditary and sporadic adrenocortical tumours is crucial for genetic counselling and disease management.
Answers are grounded in this paper and cite their sources.
Supports genetic counselling in hereditary syndromes; leaves open therapeutic targeting of defects in sporadic adrenocortical tumours.
Adrenocortical tumours (ACT), which include adenomas, carcinomas and adrenal hyperplasia, may be associated with genetic syndromes, such as Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, multiple endocrine neoplasia type 1, familial adenomatous polyposis and Carney complex. Genetic defects have been found to be responsible for the disease in most of these syndromes, allowing genetic counselling to affected patients and family members. Here, we summarize the clinical criteria of these hereditary syndromes and briefly describe the genetic alterations related to them. In addition, we discuss the involvement of various genetic defects in the development of sporadic adrenocortical tumours.
No takes yet. Share an insight, caveat, or question.
Mazzuco et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: